Shanghai MicroPort MedBot (Group) (HKG:2252) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong Kong bourse filing said.
39 orders were received for Toumai Laparoscopic Surgical Robot, while SkyWalker Orthopedic Surgical Robot saw an order volume of 25 units in 2024.
Moreover, R-ONE Vascular Interventional Surgical Robot won purchase order bids from five top public hospitals in Shanghai, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。